Results 41 to 50 of about 39,210 (233)
BackgroundEvidence is limited on factors driving target lesion revascularization (TLR) after drug-coated balloon (DCB) treatment for de novo coronary lesions.
Tommy Suharjo +3 more
doaj +1 more source
Long-term clinical safety and efficacy of drug-eluting stents in real-world patients [PDF]
Since the fi rst balloon angioplasty was performed in the late 1970’s, percutaneous coronary intervention (PCI) has undergone rapid transformation to become an essential treatment option for coronary artery disease as an alternative to surgery.
Kukreja, N. (Neville)
core +1 more source
Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation [PDF]
Background. Experimental studies have shown an activation of the angiotensin-converting enzyme (ACE) system as a response to endothelial injury. Recent publications have elucidated the hypothesis that the ACE gene polymorphism may influence the level of ...
de Jaegere, Peter +10 more
core +1 more source
Coronary arterial aneurysm formation after balloon angioplasty
The mechanism of coronary stenosis dilatation by percutaneous transluminal coronary angioplasty (PTCA) is incompletely understood. Five men who developed coronary arterial aneurysms at the site of PTCA are described. All patients were in New York Heart Association functional class III or IV at the time of PTCA. In 2 patients acute myocardial infarction
From The University of Florida, Division of Cardiovascular Medicine, Regional Veterans Administration Medical Center, Gainesville, Florida USA ( host institution ) +5 more
openaire +3 more sources
Deployable 3D‐Printed Vascular Stent with Surface‐Catalysed Endogenous Nitric Oxide Generation
A deployable 3D‐printed vascular stent was fabricated with surface‐catalyzed endogenous nitric oxide generation, representing a promising new direction for stent development. The stent can be remotely controlled by magnetic force in its compressed state and fully deployed at the target site using an untethered heat source, potentially eliminating the ...
Kun Zhou +8 more
wiley +1 more source
Balloon Angioplasty - The Legacy of Andreas Grüntzig, M.D. (1939-1985)
In 1974, at the Medical Policlinic of the University of Zürich, German-born physician-scientist Andreas Grüntzig (1939-1985) successfully applied a balloon-tipped catheter to re-open a severely stenosed femoral artery, a procedure which he initially ...
Matthias eBarton, MD, FAHA +3 more
doaj +1 more source
A lotus root‐like appearance of the coronary artery diagnosed by optical coherence tomography (OCT) is characterized by old coronary thrombi that form small lumen channels.
Wataru Takagi +4 more
doaj +1 more source
Adjunctive strategies in the management of resistant, 'undilatable' coronary lesions after successfully crossing a CTO with a guidewire. [PDF]
Successful revascularisation of chronic total occlusions (CTOs) remains one of the greatest challenges in the era of contemporary percutaneous coronary intervention (PCI).
Fairley, SL +5 more
core +1 more source
Bioabsorbable Endovascular Adhesive Tape (BEAT) for Improving Vascular Regeneration
A bioabsorbable endovascular adhesive tape (BEAT) platform based on a hierarchical polyelectrolyte complex is developed to enhance drug delivery in the DCB system. The coating enables rapid transfer to the vessel, provides short‐term mechanical support, and promotes both immediate transfer and long‐term retention of drugs at the lesion site.
Jiarong Wang +13 more
wiley +1 more source
Background. Ischemia Modified Albumin (IMA) is a biomarker of myocardial ischemia. Blood levels of IMA rise in patients who develop ischemia during percutaneous coronary intervention (PCI).
Hariadi Hariawan +2 more
doaj +1 more source

